USANA Health Sciences Files Proxy Materials
Ticker: USNA · Form: DEFA14A · Filed: Mar 27, 2024 · CIK: 896264
| Field | Detail |
|---|---|
| Company | Usana Health Sciences Inc (USNA) |
| Form Type | DEFA14A |
| Filed Date | Mar 27, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, corporate-governance
TL;DR
USANA Health Sciences filed proxy docs, nothing new for traders.
AI Summary
USANA Health Sciences, Inc. filed a Definitive Additional Materials (DEFA14A) on March 27, 2024. This filing is related to their proxy statement and indicates no fee was required for this submission. The company is incorporated in Utah and operates in the medicinal chemicals and botanical products sector.
Why It Matters
This filing is a routine part of corporate governance, providing shareholders with information related to voting and company matters.
Risk Assessment
Risk Level: low — This is a routine filing related to proxy statements and corporate governance, not indicating any immediate financial or operational risks.
Key Players & Entities
- USANA HEALTH SCIENCES INC (company) — Registrant
- 0001140361-24-015493 (filing_id) — Accession Number
- 20240327 (date) — Filing Date
- UT (state) — State of Incorporation
FAQ
What type of SEC filing is this?
This is a DEFA14A filing, specifically marked as Definitive Additional Materials.
Who is the filing company?
The filing company is USANA HEALTH SCIENCES, INC.
When was this filing submitted?
The filing was submitted on March 27, 2024.
Is there a fee associated with this filing?
No fee is required for this filing.
What is the company's primary business sector?
The company is in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, SIC code 2833.
Filing Stats: 154 words · 1 min read · ~1 pages · Grade level 12.7 · Accepted 2024-03-27 11:16:29
Filing Documents
- ny20017174x2_defa14a.htm (DEFA14A) — 8KB
- ny20017174x2_na1.jpg (GRAPHIC) — 294KB
- ny20017174x2_na2.jpg (GRAPHIC) — 292KB
- 0001140361-24-015493.txt ( ) — 816KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Mark One) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, For use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 USANA HEALTH SCIENCES, INC. (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays as currently valid OMB control number.